Evidence map›Paper›PMID 32929665›Full record

ArticleInternational ophthalmology2021

Ocular involvement in coronavirus disease 2019 (COVID-19): a clinical and molecular analysis.

Asaf Shemer, Adi Einan-Lifshitz, Amir Itah, Biana Dubinsky-Pertzov, Eran Pras, Idan Hecht

Open access · bronzeAbstract read
In one paragraph

Article in International ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. SARS-CoV-2 and the Eyes: A Review of the Literature on Transmission, Detection, and Ocular Manifestations.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Asaf ShemerDepartment of Ophthalmology, Shamir Medical Center (Formerly Assaf-Harofeh), Tzrifin, Israel.
Adi Einan-LifshitzDepartment of Ophthalmology, Shamir Medical Center (Formerly Assaf-Harofeh), Tzrifin, Israel.
Amir ItahDepartment of Ophthalmology, Shamir Medical Center (Formerly Assaf-Harofeh), Tzrifin, Israel.
Biana Dubinsky-PertzovDepartment of Ophthalmology, Shamir Medical Center (Formerly Assaf-Harofeh), Tzrifin, Israel.
Eran PrasDepartment of Ophthalmology, Shamir Medical Center (Formerly Assaf-Harofeh), Tzrifin, Israel.
Idan HechtDepartment of Ophthalmology, Shamir Medical Center (Formerly Assaf-Harofeh), Tzrifin, Israel. Idan.Hecht@gmail.com.ORCID http://orcid.org/0000-0001-5634-0432
Tel Aviv University · ILHebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCoronavirus disease 2019 (COVID-19) caused a global pandemic with millions infected worldwide. Little is known on the ocular involvement associated with the disease. The aim of this study was to assess the clinical and molecular ocular involvement among patients with confirmed COVID-19 admitted to a tertiary care facility.

methodsConsecutive patients admitted to the COVID-19 Ward of the Shamir Medical Center in Israel during March and April, 2020 were included. The control group included patients negative for COVID-19 admitted during a similar period to a different ward. Patients were examined by trained Ophthalmologists. SARS-CoV-2 conjunctival swab samples were obtained.

resultsIncluded were 48 patients, 16 with confirmed COVID-19 and 32 controls. Median patient age was 68.5 (interquartile range: 31.5, mean: 63 ± 21) years and 48% were male. Active conjunctival injection was present in three patients (19%) with COVID-19, compared to none in the controls (p = 0.034). Patients with COVID-19 were more likely to complain of foreign body sensation (31.3% vs 3.1%, p = 0.005) and redness of the eye (25% vs 0%, p = 0.003). Conjunctival injection was associated with loss of smell and taste (75% vs 7.7%, p = 0.018). Viral conjunctival swab tests all showed negative results for all three viral genes tested (E, N, and RdRp).

conclusionsAmong patients admitted to a tertiary referral center with confirmed COVID-19, active conjunctival injection was noted in one out of five cases, and was associated with loss of smell and taste. Conjunctival swabs for viral RNA were negative in patients with and without ocular involvement.

Indexed as

PandemicsAgedCOVID-19Eye Infections, ViralFemaleHumansIncidenceIsraelMaleMiddle AgedRetrospective StudiesRNA, ViralSARS-CoV-2RNA, Viral2019-nCoVCoronavirusCOVID-19OcularSARS-CoV-2

Identifiers

PMID32929665
PMCPMC7489575
OpenAlexW3085528345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.